Octopus Biosafety SA reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 0.255678 million compared to EUR 0.47011 million a year ago. Revenue was EUR 0.399284 million compared to EUR 0.577602 million a year ago.

Net loss was EUR 0.802728 million compared to EUR 1.01 million a year ago.